Evidence map›Paper›PMID 21112354›Full record

ArticleImmunology letters2011

Single cell force spectroscopy of T cells recognizing a myelin-derived peptide on antigen presenting cells.

Sabrina Hoffmann, Babak H Hosseini, Markus Hecker, Ilia Louban, Nadja Bulbuc, Natalio Garbi, Guido H Wabnitz, Yvonne Samstag, Joachim P Spatz, Günter J Hämmerling

Abstract read
In one paragraph

Article in Immunology letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sabrina Hoffmann *Division of Molecular Immunology, German Cancer Research Center DKFZ, 69120 Heidelberg, Germany.
Babak H Hosseini *Institute of Biophysical Chemistry, University of Heidelberg, and Dept. of New Materials and Biosystems, Max-Planck-Institute for Metals Research, 70569 Stuttgart, Germany.
Markus HeckerInstitute of Physiology and Pathophysiology, University of Heidelberg, Germany.
Ilia LoubanInstitute of Biophysical Chemistry, University of Heidelberg, and Dept. of New Materials and Biosystems, Max-Planck-Institute for Metals Research, 70569 Stuttgart, Germany.
Nadja BulbucDivision of Molecular Immunology, German Cancer Research Center DKFZ, 69120 Heidelberg, Germany.
Natalio GarbiDivision of Molecular Immunology, German Cancer Research Center DKFZ, 69120 Heidelberg, Germany.
Guido H WabnitzInstitute of Immunology, University of Heidelberg, Germany.
Yvonne SamstagInstitute of Immunology, University of Heidelberg, Germany.
Joachim P SpatzInstitute of Biophysical Chemistry, University of Heidelberg, and Dept. of New Materials and Biosystems, Max-Planck-Institute for Metals Research, 70569 Stuttgart, Germany.
Günter J HämmerlingDivision of Molecular Immunology, German Cancer Research Center DKFZ, 69120 Heidelberg, Germany.
Heidelberg University · DEGerman Cancer Research Center · DE

Funding

Nanomedicine development center for mechanobiologyPN2EY016586 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL LORAN · 2005 to 2014
$23.0M
NEI NIH HHS PN2 EY016586
6 · The paper itself

Abstract

T-cell recognition of peptide-MHC complexes on APCs requires cell-cell interactions. The molecular events leading to T-cell activation have been extensively investigated, but the underlying physical binding forces between T-cells and APCs are largely unknown. We used single cell force spectroscopy for quantitation of interaction forces between T-cells and APCs presenting a tolerogenic peptide derived from myelin basic protein. When T-cells were brought into contact with peptide-loaded APCs, interaction forces increased with time from about 0.5nN after 10s interaction to about 15nN after 30min. In the absence of antigen, or when ICAM-1-negative APC was used, no increase in binding forces was observed. The temporal development of interaction forces correlated with the kinetics of immune synapse formation, as determined by LFA-1 and TCR enrichment at the interface of T-cell/APC conjugates using high throughput multispectral imaging flow cytometry. Together, these results suggest that ICAM-1/LFA-1 redistribution to the contact area is mainly responsible for development of strong interaction forces. High forces will keep T-cells and APCs in tight contact, thereby providing a platform for optimal interaction between TCRs and peptide-MHC complexes.

Indexed as

Antigen-Presenting CellsCell LineIntercellular Adhesion Molecule-1Microscopy, Atomic ForceMyelin SheathPeptidesSpectrophotometryT-LymphocytesIntercellular Adhesion Molecule-1Peptides

Identifiers

PMID21112354
PMCPMC3821867
OpenAlexW1987839611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.